Quality of life measurement in chronic wounds and inflammatory skin diseases: Definitions, standards and instruments

Wound Medicine

Volumn 5, Issue , 2014, Pages 29-38

  Augustin, Matthias ^a   Langenbruch, Anna K ^a   Herberger, Katharina ^a   Baade, Katrin ^a   Goepel, Lisa ^a   Blome, Christine ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Chronic wound; Health related quality of life; HRQoL; Patient reported outcome; Quality of life measure; Skin disease

Indexed keywords

CARDIFF WOUND IMPACT SCHEDULE; CHRONIC WOUND; CONSTRUCT VALIDITY; CONVERGENT VALIDITY; COST BENEFIT ANALYSIS; CULTURAL FACTOR; DERMATITIS; DISCRIMINANT VALIDITY; FREIBURG LIFE QUALITY ASSESSMENT; HUMAN; INTERNAL CONSISTENCY; PATIENT PREFERENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SYSTEMATIC REVIEW; TEST RETEST RELIABILITY; WOUNDQOL; WURZBURG WUNDSCORE;

EID: 84901850372     PISSN: 22139095     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.wndm.2014.04.008     Document Type: Review

References (133)

1. Küchler T., Bullinger M. Onkologie. Quality of life and health economics in medicine 2000, 44-58. Ecomed, Landsberg. A. Ravens-Sieberer, A. Cieza (Eds.).
2. Radtke M.A., Reich K., Blome C., Kopp I., Rustenbach S.J., Schäfer I., et al. Evaluation of quality of care and guideline-compliant treatment in psoriasis. Development of a new system of quality indicators. Dermatology 2009, 219:54-58.
3. Quality of life and pharmacoeconomics in clinical trials 1996, Lippincott Williams and Wilkings, Philadelphia. 2nd ed. B. Spilker (Ed.).
4. Augustin M., Radtke M.A., Zschocke I., Blome C., Behechtnejad J., Schäfer I., et al. The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res 2009, 301:561-571.
5. Bullinger M. Gesundheitsbezogene Lebensqualität und subjektive Gesundheit. Überblick über den Stand der Forschung zu einem neuen Evaluationskriterium in der Medizin. PPMP 1997, 47:76-91.
6. Lange S., Zschocke I., Seidenglanz K., Schiffler A., Zöllinger A., Augustin M. Predictors of the quality of life in patient with atopic dermatitis. Dermatol Psychosom 2000, 1:66-70.
7. World Health Organization (WHO) Preamble of the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19-22 June, 1946; signed on 22 July 1946 by representatives of 61 States and entered into force on 7 April 1948 1946, 2. Official Records of the World Health Organization.
8. Bullinger M., Pöppel E. Lebensqualität in der Medizin. Schlagwort oder Forschungsansatz. Dtsch Ärzteblatt 1988, 85:C436-C437.
9. Bullinger M., Hasford J. Evaluating quality of life measures for German clinical trials. Control Clin Trials 1991, 12:914-1055.
10. Schipper H., Clinch J.J., Olweny C.H.L.M. Quality of life studies definition and conceptual issues. Quality of life and pharmacoeconomics in clinical trials 1996, 11-24. Lippincott Williams and Wilkings, Philadelphia. 2nd ed. B. Spilker, B. Spilker (Eds.).
11. Slevin M.L., Plant H., Lynch D., Drinkwater J., Gregory W.M. Who should measure quality of life, the doctor or the patient?. Br J Cancer 1988, 57:109-112.
12. Food Drug Administration (FDA) Guidance for industry: patient-reported outcome measures, use in medical product development to support labeling claims. Health Qual Life Outcomes 2006, 4:79.
13. European Medicines Agency (EMA), Committee for Medicinal Products for Human Use (CHMP) Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products, The Evaluation of Medicinal Products, Doc. Ref. EMEA/CHMP/EWP/139391/2004 2004, European Medicines Agency (EMA), London.
14. Koller M., Neugebauer E.A.M., Augustin M., Büssing A., Farin E., Klinkhammer-Schalke M., et al. Die Erfassung von Lebensqualität in der Versorgungsforschung - konzeptuelle, methodische und strukturelle Voraussetzungen. Gesundheitswesen 2009, 71:864-872.
15. Augustin M., Amon U., Braathen L., Bullinger M., Gieler U., Klein G.F., et al. Erfassung von Lebensqualität in der Dermatologie (Leitlinie). J Dtsch Dermatol Ges 2004, 9:802-806.
16. Prinsen C.A.C., Korte J., de Augustin M., Sampogna F., Salek M.S., Basra M.K.A., et al. Measurement of health-related quality of life in dermatological research and practice, introduction and recommendations by the EADV Taskforce on Quality of Life. J Eur Acad Dermatol Venereol 2013, 27:1195-1203.
17. Calvert M., Blazeby J., Revicki D., Moher D., Brundage M. Reporting quality of life in clinical trials: a CONSORT extension. Lancet 2011, 378:1684-1685.
18. Bowling A. Measuring disease, a review of disease-specific quality of life measurement scales 1995, Open University Press, Buckingham.
19. Hays R.D., Vickrey B.G., Hermann B.P., Perrine K., Cramer J., Meador K., et al. Agreement between self reports and proxy reports of quality of life in epilepsy patients. Qual Life Res 1995, 4:159-168.
20. Bullinger M., Ravens-Sieberer U. Grundlagen, Methoden und Anwendungsgebiete der Lebensqualitätsforschung bei Kindern. Prax Kinderpsychol u Kinderpsychiatrie 1995, 44:391-399.
21. Augustin M., Zschocke I., Lange S., Seidenglanz K., Amon U. Lebensqualität bei Hauterkrankungen, Vergleich verschiedener Lebensqualitäts-Fragebögen bei Psoriasis und atopischer Dermatitis. Hautarzt 1999, 50:715-722.
22. Murawski M.M., Miederhoff P.A. On the generalizability of statistical expressions of health related quality of life instrument responsiveness: a data synthesis. Qual Life Res 1998, 7:11-22.
23. Jenkinson C., Stradling J., Petersen S. How should we evaluate health status? A comparison of three methods in patients presenting with obstructive sleep apnoea. Qual Life Res 1998, 7:95-100.
24. Brecht J.G., Jenke A., Köhler M.E., Harder S., Thürmann P., Rietbrock N., et al. Empfehlungen der Deutschen Gesellschaft für Klinische Pharmakologie und Therapie zur Durchführung und Bewertung pharmakoökonomischer Studien. Med Klin 1995, 90:541-546.
25. Schulenburg J.M.G., von der Greiner W. German Recommendations on Health Economic Evaluation, Third and Updated Version of the Hanover Consensus. Value Health 2008, 11:539-544.
26. Bullinger M., Anderson R., Cella D., Aaronson N. Developing and evaluating cross-cultural instruments from minimum requirements to optimal models. Qual Life Res 1993, 2:451-459.
27. Augustin M., Wenninger K., Amon U., Schroth M.J., Küster W., Chren M., et al. German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results. Dermatology 2004, 209:14-20.
28. Juniper E.F., Guyatt G.H., Jaeschke R. How to develop and validate a new health-related quality of life instrument. Quality of life and pharmacoeconomics in clinical trials 1996, 49-56. Lippincott Williams and Wilkings, Philadelphia. 2nd ed. B. Spilker, B. Spilker (Eds.).
29. Nijsten T., Meads D.M., Korte J., de Sampogna F., Gelfand J.M., Ongenae K., et al. Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients. J Invest Dermatol 2007, 127:2315-2322.
30. Motley R.J., Finlay A.Y. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol 1992, 17:1-3.
31. Finlay A.Y., Khan G.K. Dermatology Life Quality Index (DLQI) a simple practical measure for routine clinical use. Clin Exp Dermatol 1994, 19:210-216.
32. Anderson R.T., Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997, 37:41-50.
33. Salek M.S. Measuring the quality of life patients with skin disease. Quality of life assessment key issues in the 1990s 1993, 355-370. Kluwer Academic, Lancaster. S.R. Walker, R.M. Rosser (Eds.).
34. Augustin M., Lange S., Wenninger K., Seidenglanz K., Amon U., Zschocke I. Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold system. Eur J Dermatol 2004, 14:107-113.
35. Augustin M., Herberger K., Rustenbach S.J., Schäfer I., Zschocke I., Blome C. Quality of life evaluation in wounds: validation of the Freiburg Life Quality Assessment-wound module, a disease-specific instrument. Int Wound J 2010, 7:493-501.
36. Finlay A.Y., Kelly S.E. Psoriasis - an index of disability. Clin Exp Dermatol 1987, 12:8-11.
37. Doward L.C., McKenna S.P., Kohlmann T., Niero M., Patrick D., Spencer B., et al. The international development of the RGHQoL: a quality of life measure for recurrent genital herpes. Qual Life Res 1998, 7:143-153.
38. Juniper E.F., Guyatt G.H., Andersson B., Ferrie P.J. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann Allergy 1993, 70:225-230.
39. Chren M.M., Lasek R.J., Quinn L.M., Mostow E.N., Zyzanski S.J. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996, 107:707-713.
40. Chren M.M., Lasek R.J., Flocke S.A., Zyzanski S.J. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997, 133:1433-1440.
41. Fischer T.W., Schmidt S., Strauß B., Elsner P. Hairdex - ein Instrument zur Untersuchung der krankheitsbezogenen Lebensqualität bei Haarpatienten. Hautarzt 2001, 52:219-227.
42. Lewis-Jones M.S., Finlay A.Y. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995, 132:942-949.
43. Rauch P.K., Jellinek M.S., Murphy J.M., Schachner L., Hansen R., Esterly N.B., et al. Screening for psychosocial dysfunction in pediatric dermatology practice. Clin Pediatr (Phila) 1991, 30:493-497.
44. (accessed 15.12.13). http://www.kindl.org/.
45. Psychodiagnostic measures in dermatology 2006, Hogrefe Verlag, Göttingen, Bern. J. Kupfer, S. Schmidt, M. Augustin (Eds.).
46. Motley R.J., Finlay A.Y. How much disability is caused by acne?. Clin Exp Dermatol 1989, 14:194-198.
47. Layton A.M. Acne scarring - reviewing the need for early treatment of acne. J Dermatol Treat 2000, 44:3-6.
48. Martin A.R., Lookingbill D.P., Botek A., Light J., Thiboutot D., Girman C.J. Health-related quality of life among patients with facial acne - assessment of a new acne-specific questionnaire. Clin Exp Dermatol 2001, 26:380-385.
49. Tan J., Fung K.Y., Khan S. Condensation and validation of a 4-item index of the Acne-QoL. Qual Life Res 2006, 15:1203-1210.
50. Girman C.J., Hartmaier S., Thiboutot D., Johnson J., Barber B., DeMuro-Mercon C., et al. Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual Life Res 1996, 5:481-490.
51. Basak P., Ergin S. Akne vulgarisin yaşam kalitesi üzerine etkileri. Turkderm 2000, 34:107-109.
52. Marquis P., Lecasble M., Passa P. Qualité de vie de patients souffrant d'AOMI traités par le tartrate d'ifenprodil. Résultats de l'étude ARTEMIS. Drugs 1998, 56(Suppl. 3):37-48.
53. McKenna S.P., Whalley D., Dewar A.L., Erdman R.A.M., Kohlmann T., Niero M., et al. International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD). Qual Life Res 2005, 14:231-241.
54. Whalley D., McKenna S.P., Dewar A.L., Erdman R.A., Kohlmann T., Niero M., et al. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol 2004, 150:274-283.
55. Bullinger M., Cachovan M., Creutzig A., Diehm C., Gruss J., Heidrich H., et al. Entwicklung eines krankheitsspezifischen Instruments zur Erfassung der Lebensqualität von Patienten mit arterieller Verschlußkrankheit (PAVK-86 Fragebogen). Vasa 1996, 25:32-40.
56. Chamlin S.L., Lai J., Cella D., Frieden I.J., Williams M.L., Mancini A.J., et al. Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity, and responsiveness. Arch Dermatol 2007, 143:768-772.
57. Rüden D., Staab D., Kehrt R., Wahn U. Entwicklung und Validierung eines krankheitsspezifischen Fragebogens zur Erfassung der Lebensqualität von Eltern neurodermitiskranker Kinde. J Public Health 1999, 4:335-350.
58. Warschburger P. Chronisch kranke Kinder und Jugendliche - Psychosoziale Belastung und Bewältigung 1998, Unveröffentlichte Habilitationsschrift, Bremen.
59. Lawson V., Lewis-Jones M.S., Finlay A.Y., Reid P., Owens R.G. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 1998, 138:107-113.
60. Holme S.A., Man I., Sharpe J.L., Dykes P.J., Lewis-Jones M.S., Finlay A.Y. The Children's Dermatology Life Quality Index: validation of the cartoon version. Br J Dermatol 2003, 148:285-290.
61. Lewis-Jones M.S., Finlay A.Y., Dykes P.J. The Infants' Dermatitis Quality of Life Index. Br J Dermatol 2001, 144:104-110.
62. Barnard D., Woloski M., Feeny D., McCusker P., Wu J., David M., et al. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. J Pediatr Hematol Oncol 2003, 25:56-62.
63. Juniper E.F., Howland W.C., Roberts N.B., Thompson A.K., King D.R. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol 1998, 101:163-170.
64. Holness D.L. Results of a quality of life questionnaire in a patch test clinic population. Contact Derm 2001, 44:80-84.
65. Batzdorfer L., Klippel U., Sörensen T., Schwanitz H.J. Quality of life and occupational dermatoses - development and evaluation of a questionnaire assessing quality of life with in patients with occupational dermatoses (LIOD - Life Quality Index Occupational Dermatoses). J Dtsch Dermatol Ges 2004, 2:1000-1006.
66. Morgan M., McCreedy R., Simpson J., Hay R.J. Dermatology quality of life scales - a measure of the impact of skin diseases. Br J Dermatol 1997, 136:202-206.
67. Basra M.K.A., Sue-Ho R., Finlay A.Y. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Br J Dermatol 2007, 156:528-538.
68. Chren M.M., Lasek R.J., Sahay A.P., Sands L.P. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 2001, 5:105-110.
69. Nijsten T.E.C., Sampogna F., Chren M., Abeni D.D. Testing and reducing skindex-29 using Rasch analysis: Skindex-17. J Invest Dermatol 2006, 126:1244-1250.
70. Augustin M., Zschocke I., Seidenglanz K., Lange S., Schiffler A., Amon U. Validation and clinical results of the FLQA-d, a quality of life questionnaire for patients with chronic skin diseases. Dermatol Psychosom 2000, 1:12-17.
71. Stangier U., Ehlers A., Gieler U. Fragebogen zur Bewältigung von Hautkrankheiten (FBH) 1996, Hogrefe Verlag, Göttingen.
72. Schäfer T., Staudt A., Ring J. Entwicklung des Deutschen Instrumentes zur Erfassung der Lebensqualität bei Hauterkrankungen (DIELH). Hautarzt 2001, 52:492-498.
73. Lisi P., Stingeni L., Benvenuti C., Rantuccio F., Vena G.A., Tosti A., et al. A questionnaire for the evaluation of the Italian quality of life in dermatology. Annali italiani di dermatologica clinica e sperimentale 1997, 51:39-44.
74. Ryan T.J. The confident nude or whither dermatology. Dermatolog Pract 1987, 5:8-18.
75. Stangier U., Ehlers A., Gieler U. Measuring adjustment to chronic skin disorders: validation of a self-report measure. Psychol Assess 2003, 15:532-549.
76. Wessely S.C., Lewis G.H. The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 1989, 155:686-691.
77. Grob J.J., Auquier P., Martin S., Lançon C., Bonerandi J.J. Development and validation of a quality of life measurement for chronic skin disorders in french: VQ-Dermato. The RéseaudEpidémiolo gie en Dermatologie. Dermatology 1999, 199:213-222.
78. Gurel M.S., Yanik M., Simsek Z., Kati M., Karaman A. Quality of life instrument for Turkish people with skin diseases. Int J Dermatol 2005, 44:933-938.
79. Charman C.R., Venn A.J., Williams H.C. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol 2004, 140:1513-1519.
80. Salek M.S., Finlay A.Y., Luscombe D.K., Allen B.R., Berth-Jones J., Camp R.D., et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. Br J Dermatol 1993, 129:422-430.
81. Kingsley D.H. The development and validation of a quality of life measure for the impact of androgen-dependent alopecia. Portsmouth 1999, (PhD thesis).
82. Aftergut K., Carmody T., Cruz P.D. Use of the HIV-DERMDEX quality-of-life instrument in HIV-infected patients with skin disease. Int J Dermatol 2001, 40:478-481.
83. Teale C.W., Roberts G., Hamm H., Naumann M. Development Validity, and Reliability of the hyperhidrosis impact questionnaire. Qual Life Res 2002, 11:702.
84. de Campos J.R.M., Kauffman P., Werebe E.d.C., Andrade Filho L.O., Kusniek S., Wolosker N., et al. Quality of life, before and after thoracic sympathectomy: report on 378 operated patients. Ann Thorac Surg 2003, 76:886-891.
85. Keller S., Sekons D., Scher H., Homel P., Bookbinder M. A novel scale for assessing quality of life following bilateral endoscopic thoracic sympathectomy for plamar and plantar hyperhidrosis. Abstract book of the 4th International Symposium on Sympathetic Surgery; June 28-30, Tampere, Finland 2001, Abstract O-O22.
86. Kuo C., Yen M., Lin P. Developing an instrument to measure quality of life of patients with hyperhidrosis. J Nurs Res 2004, 12:21-30.
87. Baumann L., Slezinger A., Halem M., Vujevich J., Martin L.K., Black L., et al. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis. Int J Dermatol 2005, 44:418-424.
88. Augustin M., Bross F., Földi E., Vanscheidt W., Zschocke I. Development, validation and clinical use of the FLQA-I, a disease-specific quality of life questionnaire for patients with lymphedema. Vasa 2005, 34:31-35.
89. Cormier J.N., Ross M.I., Gershenwald J.E., Lee J.E., Mansfield P.F., Camacho L.H., et al. Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire. Cancer 2008, 112:2249-2257.
90. Sigurdardóttir V., Bolund C., Brandberg Y., Sullivan M. The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique. Qual Life Res 1993, 2:193-203.
91. Balkrishnan R., McMichael A.J., Camacho F.T., Saltzberg F., Housman T.S., Grummer S., et al. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 2003, 149:572-577.
92. Rhee J.S., Matthews B.A., Neuburg M., Logan B.R., Burzynski M., Nattinger A.B. Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer. Arch Facial Plast Surg 2006, 8:314-318.
93. Matthews B.A., Rhee J.S., Neuburg M., Burzynski M.L., Nattinger A.B. Development of the facial skin care index: a health-related outcomes index for skin cancer patients. Dermatol Surg 2006, 32:924-934. discussion 934.
94. Drake L.A., Patrick D.L., Fleckman P., Andr J., Baran R., Haneke E., et al. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol 1999, 41:189-196.
95. Turner R.R., Testa M.A. Measuring the impact of onychomycosis on patient quality of life. Qual Life Res 2000, 9:39-53.
96. Warshaw E.M., Foster J.K., Cham P.M.H., Grill J.P., Chen S.C. NailQoL: a quality-of-life instrument for onychomycosis. Int J Dermatol 2007, 46:1279-1286.
97. Lubeck D.P., Gause D., Schein J.R., Prebil L.E., Potter L.P. A health-related quality of life measure for use in patients with onychomycosis: a validation study. Qual Life Res 1999, 8:121-129.
98. Potter L.P., Mathias S.D., Raut M., Kianifard F., Tavakkol A. The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis. Health Qual Life Outcomes 2006, 4:50.
99. Koo J.Y.M., Kowalski J., Guenther L. Quality of life effect of oral tazarotene in patients with moderate to severe psoriasis as measured by the 12-item psoriasis quality of life questionnaire (PQOL-12). J Am Acad Dermatol 2004, 50:149.
100. Gupta M.A., Gupta A.K. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol 1995, 75:240-243.
101. McKenna S.P., Doward L.C., Whalley D., Tennant A., Emery P., Veale D.J. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 2004, 63:162-169.
102. McKenna S.P., Cook S.A., Whalley D., Doward L.C., Richards H.L., Griffiths C.E.M., et al. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol 2003, 149:323-331.
103. Desai N.S., Poindexter G.B., Monthrope Y.M., Bendeck S.E., Swerlick R.A., Chen S.C. A pilot quality-of-life instrument for pruritus. J Am Acad Dermatol 2008, 59:234-244.
104. Inanir I., Aydemir O., Gündüz K., Danaci A.E., Türel A. Developing a quality of life instrument in patients with psoriasis: the Psoriasis Quality of Life Questionnaire (PQLQ). Int J Dermatol 2006, 45:234-238.
105. Coaccioli S., Di Cato L., Bruni P.L., Papini M., Puxeddu A. Qualità della vita nell'artrite psoriasica. Proposta di un questionario per la valutazione. Recenti Prog Med 2003, 94:380-386.
106. Juniper E.F., Thompson A.K., Ferrie P.J., Roberts J.N. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999, 104:364-369.
107. Juniper E.F., Guyatt G.H. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991, 21:77-83.
108. Juniper E.F., Thompson A.K., Ferrie P.J., Roberts J.N. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000, 30:132-140.
109. Juniper E.F., Rohrbaugh T., Meltzer E.O. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2003, 111:484-490.
110. Kupfer J., Brosig B., Gottwald B., Niemeier V., Gieler U. Überprüfung der Sensitivität eines Fragebogens zur Lebensqualität bei Patienten mit allergischer Rhinitis. Allergologie 2001, 24:300-308.
111. Nicholson K., Abramova L., Chren M., Yeung J., Chon S.Y., Chen S.C. A pilot quality-of-life instrument for acne rosacea. J Am Acad Dermatol 2007, 57:213-221.
112. Chen S.C., Yeung J., Chren M. Scalpdex: a quality-of-life instrument for scalp dermatitis. Arch Dermatol 2002, 138:803-807.
113. Leong K.P., Kong K.O., Thong B.Y.H., Koh E.T., Lian T.Y., Teh C.L., et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology (Oxford) 2005, 44:1267-1276.
114. McElhone K., Abbott J., Shelmerdine J., Bruce I.N., Ahmad Y., Gordon C., et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum 2007, 57:972-979.
115. Steen V.D., Medsger T.A. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997, 40:1984-1991.
116. Khanna D., Hays R.D., Park G.S., Braun-Moscovici Y., Mayes M.D., McNearney T.A., et al. Development of the Scleroderma Gastrointestinal Tract 1.0 (SSc-GIT 1.0) Quality of Life Instrument. Arthritis Rheum 2007, 15:1280-1286.
117. Dhawan V., Spratt K.F., Pinzur M.S., Baumhauer J., Rudicel S., Saltzman C.L. Reliability of AOFAS diabetic foot questionnaire in Charcot arthropathy: stability, internal consistency, and measurable difference. Foot Ankle Int 2005, 26:717-731.
118. Bann C.M., Fehnel S.E., Gagnon D.D. Development and validation of the Diabetic Foot Ulcer Scale-Short Form (DFS-SF). PharmacoEconomics 2003, 21:1277-1290.
119. Hyland M.E., Ley A., Thomson B. Quality of life of leg ulcer patients: questionnaire and preliminary findings. J Wound Care 1994, 3:294-298.
120. Price P., Harding K. Cardiff Wound Impact Schedule: the development of a condition-specific questionnaire to assess health-related quality of life in patients with chronic wounds of the lower limb. Int Wound J 2004, 1:10-17.
121. Smith J.J., Guest M.G., Greenhalgh R.M., Davies A.H. Measuring the quality of life in patients with venous ulcers. J Vasc Surg 2000, 31:642-649.
122. Hareendran A., Doll H., Wild D.J., Moffatt C.J., Musgrove E., Wheatley C., et al. The venous leg ulcer quality of life (VLU-QoL) questionnaire: development and psychometric validation. Wound Repair Regen 2007, 15:465-473.
123. Baiardini I., Pasquali M., Braido F., Fumagalli F., Guerra L., Compalati E., et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 2005, 60:1073-1078.
124. Smith J.J., Garratt A.M., Guest M., Greenhalgh R.M., Davies A.H. Evaluating and improving health-related quality of life in patients with varicose veins. J Vasc Surg 1999, 30:710-719.
125. Augustin M., Dieterle W., Zschocke I., Brill C., Trefzer D., Peschen M., et al. Development and validation of a disease-specific questionnaire on the quality of life of patients with chronic venous insufficiency. Vasa 1997, 26:291-301.
126. Klyscz T., Jünger M., Schanz S., Janz M. Lebensqualität bei chronisch venöser Insuffizienz (CVI). Ergebnisse einer Untersuchung mit dem neu entwickelten Tübinger Fragebogen zur Messung der Lebensqualität von CVI-Patienten (TLQ-CVI). Hautarzt 1998, 49:372-381.
127. Launois R., Reboul-Marty J., Henry B. Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ). Qual Life Res 1996, 5:539-554.
128. Badia X., Colombo J.A., Lara N., Llorens M.A., Olmos L., Sainz de los Terreros M., et al. Combination of qualitative and quantitative methods for developing a new Health Related Quality of Life measure for patients with anogenital warts. Health Qual Life Outcomes 2005, 3:24.
129. Finlay A.Y. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997, 136:305-314.
130. Blome C., Simianer S., Purwins S., Laass A., Rustenbach S.J., Schaefer I., et al. Time needed for treatment is the major predictor of quality of life in psoriasis. Dermatology 2010, 221:154-159.
131. Acquadro C., Price P., Wollina U. Linguistic validation of the Cardiff Wound Impact Schedule into French, German and US English. J Wound Care 2005, 14:14-17.
132. Spech E., Faller H., Franke A., Thiede A., Debus E.S. Der Würzburger Wundscore (WWS): Ein neuer Lebensqualitätsfragebogen. Zeitschrift für Wundheilung 2003, 8:40-42.
133. Blome C., Baade K., Debus E.S., Price P., Augustin M. The 'Wound-QoL': a short questionnaire measuring quality of life in patients with chronic wounds based on three established disease-specific instruments. Wound Repair Regen 2014, accepted 21.04.14.